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Abstract
Surveillance indicates that tick-borne diseases are a common problem in the United States. 
Nevertheless, little is known regarding the experience or management practices of healthcare 
providers who treat these conditions. The purpose of the present study was to characterize the 
frequency of tick-borne diseases in clinical practice and the knowledge of healthcare providers 
regarding their management. Four questions about tick-borne diseases were added to the 2009 
Docstyles survey, a nationally representative survey of >2000 U.S. healthcare providers. Topics 
included diseases encountered, management of patients with early Lyme disease (LD), provision 
of tick-bite prophylaxis, and sources of information on tick-borne diseases. Overall, 51.3% of 
practitioners had treated at least one patient for a tick-borne illness in the previous year. Among 
these, 75.1% had treated one type of disease, 19.0% two types of disease, and 5.9% three or more 
diseases. LD was encountered by 936 (46.8%) providers; Rocky Mountain spotted fever was 
encountered by 184 (9.2%) providers. Given a scenario involving early LD, 89% of providers 
would prescribe antibiotics at the first visit, with or without ordering a blood test. Tick-bite 
prophylaxis was prescribed by 31.0% of all practitioners, including 41.1% in high-LD-incidence 
states and 26.0% in low-incidence states. Tick-borne diseases are encountered frequently in 
clinical practice. Most providers would treat early LD promptly, suggesting they are 
knowledgeable regarding the limitations of laboratory testing in this setting. Conversely, providers 
in low-LD-incidence states frequently prescribe tick-bite prophylaxis, suggesting a need for 
education to reduce potential misdiagnosis and overtreatment.
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Introduction
North American ticks transmit a diverse array of diseases with clinical features that range 
from mild and self-limited to fulminant and life-threatening. Lyme disease (LD), caused by 
Borrelia burgdorferi, is by far the most common with approximately 30,000 cases reported 
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each year to the Centers for Disease Control and Prevention (CDC). Less common but 
potentially fatal is Rocky Mountain spotted fever (RMSF), caused by Rickettsia rickettsii. 
Other endemic diseases associated with ticks include anaplasmosis, babesiosis, Colorado 
tick fever, ehrlichiosis, Powassan encephalitis, southern tick-associated rash illness 
(STARI), tick-borne relapsing fever (TBRF), tularemia, tick paralysis, and recently 
described infections with B. miyamotoi, with a new ehrlichia species in Wisconsin, and a 
novel phlebovirus (Krause et al., 2013; McMullan et al., 2012; Pritt et al., 2011). Tick-borne 
diseases occur throughout the United States, although the geographic distribution of 
individual diseases varies.
Early detection and appropriate treatment is crucial for reducing morbidity and mortality due 
to tick-borne pathogens. Unfortunately, timely diagnosis and management may be hindered 
due to unrecognized tick bites, non-specific symptoms, or a lack of familiarity on the part of 
the health care provider. In addition, providers may be called upon by concerned patients to 
provide prophylaxis following a recognized tick bite. Prophylaxis can be effective in 
preventing LD; however the circumstances where this is considered beneficial are complex 
and require substantial knowledge on the part of the provider (Fix et al., 1998; O’Reilly et 
al., 2003; Warshafsky et al., 2010). There is currently no evidence that posttick bite 
prophylaxis is effective for preventing other tick-borne diseases.
To better characterize current provider experiences related to tick-borne diseases in the 
United States, questions were developed for a representative, nationwide survey of U.S. 
healthcare providers. Previous surveys focused on LD and were conducted in LD-endemic 
states (Eppes et al., 1994; Magri et al., 2002; Murray and Feder, 2001; Strickland et al., 
1994). The goals were to determine how commonly providers see patients with tick-borne 
diseases, what they know about diagnosis and management of selected diseases, what their 
practices are with regard to post-tick bite prophylaxis, and where they obtain information 
regarding tick-borne diseases.
Methods
DocStyles is a web-based survey of physicians and nurse practitioners conducted by Porter 
Novelli, a public relations firm with a specialty practice in health and social marketing. 
Physicians are drawn from the Epocrates’ Honors Panel, an opt-in panel of over 156,000 
medical practitioners who are verified against the American Medical Association’s (AMA) 
master file by name, birthdate, medical school, and graduation date. Physicians are 
randomly sampled from the Panel to match the proportions for age, gender, and region 
within AMA’s master file. They are also screened for the following criteria: practice within 
the United States, actively seeing patients, and practicing for at least 3 years. Nurse 
practitioners are drawn from Epocrates’ Allied Health Panel which includes over 44,500 
nurse practitioners and ~1600 registered dietitians. Survey quotas were set to reach 1000 
primary care physicians (Internist, Family/General practice), 250 pediatricians, 250 OB/
GYNs, 250 dermatologists, 250 nurse practitioners, and 150 registered dieticians. Invitations 
to participate are sent electronically in numbers estimated to yield the desired quotas of 
completed questionnaires. Once a sampling quota for a provider type is met, the survey 
website prevents additional respondents in that specialty. The survey takes an estimated 30–
Brett et al. Page 2













40 min to complete, and participants are paid an honorarium of $55–$95 for completing the 
survey. CDC licenses the results of DocStyles surveys from Porter Novelli. Analyses of 
these results were exempt from institutional review board approval because personal 
identifiers were not included in the data provided to CDC. Responses from dietitians were 
excluded as these providers are not expected to be directly involved in diagnosing infectious 
diseases.
The 2009 DocStyles survey was comprised of approximately 140 questions covering 
practices related to a wide range of health topics (e.g., tobacco use, sexually transmitted 
diseases, influenza vaccination, gynecologic procedures), as well as practitioner 
demographic information, practice characteristics, and practitioner type. Four questions 
regarding tick-borne diseases were dispersed among the other questions:
1. “I am knowledgeable regarding the diagnosis and clinical management of tick-
borne diseases.” (Select one: strongly agree, agree, neither agree nor disagree, 
disagree, strongly disagree.)
2. “For which of the following tick-borne disease have you treated a patient in the last 
year?” (Select all that apply: Lyme disease, Rocky Mountain spotted fever, 
ehrlichiosis or anaplasmosis, tularemia, babesiosis, southern tick-associated rash 
illness, tickbite prophylaxis, none of these.)
3. “An otherwise healthy patient with no previous history of tick-borne diseases 
presents to your office with a large, circular, “bull’s-eye” rash around a site where 
he had removed an engorged tick 7 days earlier. Which of the following best 
describes what you would do during the first visit?” (Select one: order a blood test 
for Lyme disease and await the results before treating; order a blood test for Lyme 
disease and begin empiric antibiotics; begin empiric antibiotics without ordering a 
blood test; reassure the patient and have them return if symptoms do not improve; 
none of these.)
4. “From which of the following sources do you get information on the management 
of tick-borne disease?” (Select all that apply: CDC website, NIH website, other 
websites, Guidelines from the Infectious Diseases Society of America, articles by 
the International Lyme and Associated Diseases Society, other published materials, 
professional meetings, none of these, I don’t treat patients with tick-borne 
diseases.)
Data analysis was conducted in 2012. SAS JMP 9.0.2 (Cary, NC) was used for all analyses. 
Chi-square tests were used to compare practitioner characteristics of those who had and had 
not treated a patient with tick-borne illnesses in the previous year. If values were ≤5, 
Fisher’s exact test was used. Variables with a p value <0.05 in the univariate analysis were 
included in mutivariable logistic regression model. Practitioners were also compared 
according to the incidence of LD in their practice area. For purposes of this analysis, 14 
states (Delaware, Connecticut, New Hampshire, Massachusetts, Maine, New Jersey, 
Vermont, Pennsylvania, Wisconsin, Maryland, New York, Minnesota, Rhode Island, 
Virginia) and the District of Columbia were defined as high-LD-incidence areas based on 
having a reported incidence greater than the national average of 9.4 confirmed cases/
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100,000 population in 2008. Collectively, these jurisdictions accounted for approximately 
97% of all confirmed LD cases reported to CDC in that year.
Results
Invitations were sent to 4937 practitioners in order to obtain 2261 responses, for a response 
rate of 48.5%, as calculated by Porter Novelli. Fifty-seven providers did not meet inclusion 
criteria for active practice in the United States for at least 3 years, and 54 others did not 
complete the survey, yielding a total of 2150 completed surveys. After excluding registered 
dieticians, 2000 practitioners were included in this analysis, of which 1750 (87.5%) were 
physicians and 250 (12.5%) were nurse practitioners (NPs; Table 1). The median age of all 
practitioners was 43 years (range: 27–95 years). Providers were predominantly non-Hispanic 
whites (1463/2000; 73.2%). Median time in practice was 12.5 years (range: 3–46 years), and 
practitioners reported seeing a median of 101 patients per week (range: 10–650). 
Practitioners were from 49 states and the District of Columbia (Table 1). Overall, 665 
(33.3%) of 2000 providers practiced in states meeting the definition of high LD incidence.
When rating their knowledge of tick-borne diseases, 1393 (69.7%) of 1999 practitioners 
agreed or strongly agreed that they were knowledgeable about the management of tick-borne 
diseases, 354 (17.7%) neither agreed nor disagreed, and 254 (12.7%) disagreed or strongly 
disagreed. Dermatologists were most likely to agree or strongly agree (88.8%), whereas NPs 
(63.2%) and OB/GYNs (31.6%) were least likely. Practitioners in high-LD-incidence states 
were more likely to respond that they were knowledgeable regarding tick-borne diseases 
than those from low-incidence states (79.0% vs. 65.0%, p < 0.0001). Similarly, those who 
saw >100 patients per week (OR = 1.3, 95% CI 1.1–1.6), were male (OR = 1.4, 95% CI 1.1–
1.7), or were ≤40 years-old (OR = 1.3, 95% CI 1.0–1.5) were more likely to agree that they 
were knowledgeable about tick-borne diseases. All of these factors remained statistically 
significant in the multivariable analysis.
A total of 1025 (51.3%) of 2000 practitioners reported treating ≥1 patient with a tick-borne 
disease in the previous year (Table 2). Among these, 770 (75.1%) had treated only one type 
of tick-borne disease, 195 (19.0%) had treated 2 types of tick-borne disease, and 60 (5.9%) 
had encountered ≥3 types of tick-borne disease. The most common illness was LD, 
encountered by 936 (46.8%) providers, followed by RMSF encountered by 184 (9.2%) 
providers. Overall, 492 (74.0%) of 665 clinicians in high-LD-incidence states and 444 
(33.3%) of 1335 practitioners in low-LD-incidence states reported treating a patient with 
LD. Among practitioners treating RMSF, 100 (54.3%) were from southeastern states, which 
account for 68% of RMSF cases reported to CDC in 2008 (CDC, 2010). Practitioners who 
had treated LD did not differ with regard to age, sex, race, ethnicity, practice setting, or 
years in practice from those who had not. In contrast, practitioners who had treated RMSF 
were more likely to be male (OR = 1.4, 95% CI 1.0–1.9), to treat >100 patients per week 
(OR = 1.5, 95% CI 1.1–2.1), and to practice in the south (OR = 2.6, 95% CI 1.9–3.6). 
Ninety-five (52%) of 184 providers who diagnosed RMSF also diagnosed at least one case 
of LD.
Brett et al. Page 4













Thirty-one percent of all providers had prescribed tick-bite prophylaxis for one or more 
patients in the previous year, with a higher frequency among dermatologists (41.2%) and 
family practitioners (39.7%), and a lower frequency among pediatricians (22.8%) and OB/
GYNs (12.0%). Overall, 273 (41.1%) of 665 practitioners in high-LD-incidence states and 
347 (26.0%) of 1335 practitioners in low-incidence states provided tick-bite prophylaxis in 
the previous year. Clinicians in high-LD-incidence states were significantly more likely to 
have prescribed tick-bite prophylaxis (OR = 2.0, 95% CI 1.6–2.4), as were those who saw 
more than 100 patients per week (OR = 1.5, 95% CI 1.3–1.9) or had been practicing for 
longer than 10 years (OR = 1.3, 95% CI 1.1–1.6). Additionally, practitioners in individual 
practices were more likely to have prescribed prophylaxis relative to those in group practices 
(OR = 1.5, 95% CI 1.1–1.8) or hospital practices (OR = 2.1, 95% CI 1.1–1.8). Among the 
1025 providers who treated a patient with a tick-borne disease in the past year, the 
proportion of practitioners who prescribed tick-bite prophylaxis was similar among those 
who reported treating patients for LD and those who only treated other tick-borne diseases 
(43.8% vs. 44.2%, p = 0.94).
When presented with a scenario describing a patient with a large, circular, “bull’s-eye” rash 
around a site where he/she had removed an engorged tick 7 days earlier, 1412 (70.6%) of 
2000 providers would prescribe antibiotics and order a blood test for Lyme disease, 373 
(18.7%) would begin antibiotics without ordering a blood test, 85 (4.3%) would order a test 
and await results, 15 (0.8%) would reassure the patient and have them return if symptoms do 
not improve, and 115 (5.8%) opted for none of these. Combining these responses, 1785 
(89.3%) of the 2000 providers would prescribe empiric antibiotics at the time of the first 
visit. Empiric antibiotics were prescribed more often by providers in high-LD-incidence 
states (91.2% vs. 88.2%, p < 0.05) and by providers other than OB/GYNs (92.6% vs. 66.0%, 
p < 0.001). Excluding OB/GYNs, empiric antibiotics were provided by 93.9% of providers 
in high-LD-incidence states. Clinicians who had treated a patient with LD in the past year 
were more likely to select an option that included empiric antibiotics (OR = 3.4, 95% CI 
2.5–4.8), as were providers who responded positively about their knowledge of tick-borne 
diseases (OR = 6.4, 95% CI 4.7–8.7). Overall, 95% of providers who responded positively 
about their knowledge of tick-borne diseases would prescribe antibiotics at the first visit, as 
compared with only 65% of providers who responded negatively. Otherwise, there were no 
other notable differences in the age, sex, years in practice, or practice setting between 
practitioners who would and would not prescribe empiric antibiotics. With respect to testing, 
74.9% of all providers would order a blood test for LD, with lower rates among OBS/GYNs 
(67.2%) and pediatricians (68%). Providers in high-LD-incidence states were more likely to 
prescribe antibiotics without ordering a blood test for LD (OR = 2.2, 95% CI 1.7–2.7, p < 
0.0001), as were pediatricians (OR = 2.2, 95% CI 1.6–2.9). OB/GYNs were least likely to 
prescribe antibiotics without testing (OR = 0.2, 95% CI 0.1–0.3).
Among 1775 practitioners who reported treating patients for tick bite or a tick-borne disease, 
1436 (80.9%) consulted websites, 406 (22.9%) attending professional meetings, and 375 
(21.1%) used guidelines and other published materials to obtain information on management 
of tick-borne diseases. Websites were used most commonly by OB/GYNs (93.2%) and least 
often by dermatologists (69.6%). There were no differences among website users by work 
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setting, age, number of patients per week, or years of practice. Obtaining information from 
professional meetings was more common among practitioners who were >40 years of age 
(25.5% vs. 19.1%), worked in individual practices (28.2% vs. 21.6% overall), were 
dermatologists (42.9% vs. 24.6% other provider types), or saw >100 patients per week 
(26.1% vs. 19.6%). Use of published materials was more common among practitioners who 
practiced in a hospital or clinic settings (31.6% vs. 18.8%), were internists (30.5% vs. 17.4% 
other provider types), or saw ≤100 patients per week (23.4% vs. 18.6%).
Discussion
In this representative nationwide survey of 2000 U.S. health-care providers, over 51% 
reported treating at least one patient for a tick-borne disease during the previous year. 
Because the survey concerned a wide range of topics, this result is unlikely to reflect 
differential participation by treating providers. Certain types of providers were more likely 
to treat tick-borne diseases; however, all provider types saw such patients, including nearly 
20% of OB/GYNs. The proportion of providers diagnosing specific diseases generally 
mirrored the occurrence and ranking of these diseases as measured through national 
surveillance. LD, with ~30,000 cases reported annually, was diagnosed by far more 
providers than RMSF (~2500 reported cases), which was diagnosed by slightly more 
providers than anaplasmosis or ehrlichiosis (~2000 reported cases), babesiosis (~1000 
reported cases), and tularemia (~150 reported cases) (CDC, 2013). Similarly, the geographic 
distribution of physician diagnoses is consistent with surveillance data. LD and babesiosis 
were diagnosed most often by providers in the Northeast, RMSF most often by providers in 
the Southeast.
Despite these consistencies, the absolute percentage of providers treating tick-borne disease 
is higher than might be expected, particularly the percentage treating patients for LD in low-
incidence areas (33%). Overdiagnosis almost certainly plays a role in this finding (Ley et al., 
1994; Reid et al., 1998). Given the ease of treating common tick-borne diseases with oral 
antimicrobials, many providers may be treating patients for infections that are suspected 
rather than confirmed. For LD in particular, confusion with STARI is likely in areas where 
A. americanum ticks are common (Campbell et al., 1995; Wormser et al., 2005). 
Nevertheless, provider’s tendency to treat may not be entirely baseless. “Low-incidence 
areas” includes several states with large populations where LD is nevertheless endemic (e.g., 
California, Illinois, Ohio, and Michigan). Furthermore, ours is a highly mobile society, and 
providers in low-incidence areas are likely to have at least some patients with recent travel 
to a high risk area. In this regard, it is important to note that treating a single traveler for a 
suspected tick-borne disease, among hundreds or thousands of patients evaluated each year, 
would generate a “yes” response in this survey for treating that disease. While treatment 
may be out of proportion with the occurrence of true infections, this does not negate the 
observation that providers frequently encounter illnesses that either are or they consider to 
be tick-borne.
Nearly one-third of surveyed providers reported prescribing antibiotics for post-tick bite 
prophylaxis. Prophylaxis has been shown effective only for preventing LD. Furthermore, it 
is only recommended in highly specific circumstances, i.e., when it can be administered 
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within 72 h of removing an engorged Ixodes scapularis tick with a ≥20% probability of 
being infected (Nadelman et al., 2001; Wormser et al., 2006). The proportion of providers 
who prescribed tick-bite prophylaxis was greater in high-incidence areas; nevertheless, as 
with LD treatment, a substantial proportion (26.0%) of providers in low-incidence areas also 
prescribed tick-bite prophylaxis. These results suggest a need for provider education 
regarding the uses and the limitations of tick-bite prophylaxis. Additionally, talking points 
for providers may be useful to guide discussions with their patients about the reasons for and 
against tick-bite prophylaxis for tick-borne diseases.
This survey found that almost 90% of U.S. practitioners would treat patients with erythema 
migrans (EM) with empiric antibiotics at the first visit; this increased to 95% among 
providers who had treated a patient for LD in the past year. EM remains a clinical diagnosis 
based on appearance and knowledge of epidemiologic features of Lyme disease such as 
seasonality, endemic areas, and potential exposure to tick habitats. Guidelines emphasize the 
need to treat patients with EM empirically (Wormser et al., 2006) given that serologic 
testing can be negative early in disease (Aguero-Rosenfeld et al., 2005), and treatment may 
prevent complications (Feder et al., 2006). Although EM is a clinical diagnosis, 
approximately 75% of providers would have ordered concurrent laboratory testing for a 
patient with EM. Many different factors may motivate testing, including the difficulty in 
distinguishing EM from other rashes (Feder and Whitaker, 1995; Tibbles and Edlow, 2007), 
a desire to confirm the diagnosis (Kassirer, 1989), lack of knowledge regarding test 
characteristics in early Lyme disease (Tugwell et al., 1997), medico-legal concerns, or 
patient requests. Among the types of practitioners surveyed, pediatricians were less likely 
than most other practitioners to order blood tests, perhaps due to concerns surrounding 
venipuncture in children (Kennedy et al., 2008). The more limited laboratory testing by 
pediatricians did not influence the proportion who would provide antibiotics at the first visit 
or who would prescribe antibiotics without laboratory testing. In contrast, OB/GYNs were 
less likely to order blood tests and were less likely to treat a patient with EM at the first visit. 
Reticence to treat empirically may reflect concern of the use of medications during 
pregnancy, and OB/GYNs may be more likely to refer such patients to another provider, a 
management option that was not included in this survey. OB/GYNs were the least likely 
group in this survey to encounter patients with LD, and this may impact knowledge about 
current recommendations. Nevertheless, although they encounter patients with LD less 
commonly, they may also be the only point of contact with the healthcare system. Therefore, 
OB/GYN-targeted educational resources on tick-borne diseases, particularly LD, may be 
helpful.
Almost 70% of practitioners were confident about their knowledge of tick-borne diseases 
management, but this varied by practitioner type and the frequency with which they 
encountered any tick-borne disease. When uncertain about tick-borne diseases, providers 
used a wide variety of sources to obtain information, with websites being by far the most 
frequently used resource. This information should guide the development of educational 
resources for specific provider groups.
Our findings are subject to several limitations. In regard to the DocStyles survey, healthcare 
providers who chose not to participate may have answered the tick-borne disease questions 
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differently than those who did participate. These results may, therefore, not be generalizable 
to all U.S. healthcare providers. The answers to tick-borne disease questions are self-
reported and may differ from providers’ actual knowledge and practice. Additionally, the 
survey instrument does not lend itself to an evaluation of nuanced treatment decisions. 
Lastly, the DocStyles questionnaire has not been evaluated for validity or reliability. This 
specific study did not assess reasons for LD treatment in low-incidence areas or for ordering 
blood tests for patients with EM. The number of patients treated for LD by each provider 
was not determined, which would have allowed for better quantification of the public health 
burden of disease. In addition, tick-bite prophylaxis was not explicitly defined with respect 
to antibiotic type and duration, nor could specific diseases or disease the provider intended 
to prevent be determined. In future surveys, inclusion of other providers such as physician 
assistants and emergency medicine physicians would be valuable because they likely 
encounter patients with tick-borne diseases. Finally, other practice patterns such as prompt 
referral or consultation that may be appropriate management options were not assessed.
Tick-borne diseases, or at least clinically similar conditions, are commonly encountered by 
practitioners throughout the United States. Most clinicians would treat early LD 
appropriately with antibiotics at the first visit; however, more detailed information and 
resources regarding EM diagnosis, the characteristics of test results in early LD, and the 
need for early treatment among specific practitioner groups are suggested by this survey. 
Practice patterns related to tick-bite prophylaxis may help guide future provider education. 
Developing tick-borne diseases resources for OB/GYNs with a focus on LD might help 
improve early treatment for EM.
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Table 1
Characteristics of 2000 practitioners surveyed for DocStyles 2009.
Characteristics n (%)
Sex
  Male 1220 (61.0)
  Female 780 (39.0)
Age
  ≤40 years 803 (40.2)
  >40 years 1197 (59.8)
Race
  White 1538 (76.9)
  Asian 289 (14.5)
  Other 96 (4.8)
  Black or African American 77 (3.9)
Ethnicity
  Non-Hispanic 1902 (95.1)
  Hispanic 98 (4.9)
Region
  Southa 676 (33.8)
  Northeastb 507 (25.4)
  Midwestc 423 (21.2)
  Westd 394 (19.7)
LD incidence
  High-LD-incidence states 665 (33.3)
  Low-LD-incidence states 1335 (66.7)
Practitioner type
  Family/general practice 609 (30.5)
  Internist 391 (19.5)
  Dermatologist 250 (12.5)
  Nurse practitioner 250 (12.5)
  Obstetrician/gynecologist 250 (12.5)
  Pediatrician 250 (12.5)
Practice setting
  Group 1271 (63.6)
  Hospital 367 (18.4)
  Individual 362 (18.1)
Years of practice
  ≤10 856 (42.8)
  >10 1144 (57.2)
Patients per week
  ≤100 1104 (55.2)
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Characteristics n (%)
  >100 896 (44.8)
a
Southern states included: AL, AR, District of Columbia, DE, FL, GA, KY, LA, MD, MS, NC, OK, SC, TN, TX, VA, and WV.
b
Northeastern states included: CT, MA, ME, NH, NJ, NY, PA, RI, and VT.
c
Midwestern states included: IA, IL, IN, KS, MI, MN, MO, ND, NE, OH, SD, and WI.
d
Western states included: AK, AZ, CA, CO, HI, ID, MT, NM, NV, OR, UT, WA, and WY.
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